AQST 8-K 2026-11-03

Aquestive Therapeutics, Inc. (AQST) 8-K dated 2026-11-03 — accession 0001398733-26-000073.

Aquestive Therapeutics, Inc. (AQST) is a drug manufacturers - specialty & generic company listed on US.

Aquestive Therapeutics, Inc. filed a 8-K on 2026-11-03. Accession 0001398733-26-000073.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported AQST revenue for 2025-12-31 was $44.5M. Net income was -$83.8M. Revenue was down 22.6% from 2024-12-31 to 2025-12-31. AQST currently screens at market cap $493.0M.

Not investment advice. The AQST SEC hub lists recent forms. The stock page is the research view.